FTC and five states sue Hims & Hers over health data privacy and billing

The FTC’s amended lawsuit against Hims & Hers adds five states and sharpens allegations over sensitive health data, recurring charges, and cancellation barriers. The case could shape how telehealth companies handle privacy promises and subscription design.

FTC and five states sue Hims & Hers over health data privacy and billing
Type
Child
Status
Approved
Title (YouTube)
Images Failed (Social)
Do not index
Publish Date (TikTok)
Videos Post IDs (Social)
Hashtags (Social)
Caption
Caption X
Cover
hims-hers-health-data-privacy-billing.png
OG Image
hims-hers-health-data-privacy-billing.png
Alt Image Text
Flat vector illustration of Hims & Hers health data privacy and billing dispute, showing a telehealth app sharing sensitive health data to ad networks with billing and cancellation warning symbols.
Images
Videos
Publish Date (Social)
Scheduled (Social)
Images Posted (Social)
Videos Posted (Social)
Featured
Created time
Nov 11, 2026 04:40 PM
Sub-item
Authors
CTA Practice Area (Social)
TikTok Failed (Social)
Videos Post Links (Social)
TikTok Post Links (Social)
Images Post IDs (Social)
YT Post ID
Video Pending Manual (Social)
TikTok Posted (Social)
TikTok Post IDs (Social)
Video Cover (Social)
Images Post Links (Social)
First Comment (Social)
Videos Failed (Social)
YT Embedded
Images Delete (Social)
Videos Delete (Social)
Carousel Video URL (Social)
The Federal Trade Commission said on November 10, 2026 that it filed an amended complaint against Hims & Hers in the U.S. District Court for the Northern District of California, adding Arizona, Florida, Nebraska, Ohio, and Wisconsin as co-plaintiffs. The case expands an earlier privacy and subscription lawsuit and alleges the telehealth company shared sensitive health information with advertising platforms while also misleading consumers about recurring charges and cancellation.
According to the FTC, the amended federal lawsuit builds on a case first filed in July 2026 by the agency, Utah, and California through Los Angeles County Counsel. Regulators say Hims & Hers disclosed information tied to conditions involving sexual health and mental health to third parties such as Meta and Snap despite privacy promises, and they also contend the company made subscription cancellation harder than consumers expected.

What The Government Is Alleging

At the center of the case is the FTC’s pending action against Hims & Hers, which now includes claims under the FTC Act, the Restore Online Shoppers’ Confidence Act, and multiple state consumer protection laws. The newly added states join California and Utah, broadening the case from a two-state partnership into a larger multistate enforcement action.
The government’s allegations fall into two buckets.
First, the complaint says Hims & Hers shared sensitive health information with third-party advertising platforms after telling users its services protected privacy. The FTC describes this information as connected to highly personal medical topics, including treatment-related details involving sexual health and mental health. In general terms, that kind of allegation matters because health-related data often carries a very different level of sensitivity than ordinary browsing data. The FTC has recently highlighted privacy and security enforcement actions involving health and digital platforms as a major focus area.
Second, the complaint challenges the company’s billing and cancellation practices. Regulators allege consumers were charged for prescriptions almost immediately after submitting an intake form, even though the company’s marketing suggested they would first have a chance to consult with a provider and determine the right treatment. The complaint also says the company failed to provide simple cancellation mechanisms for recurring charges, an issue that appears in the ROSCA counts of the amended filing.
This latest filing also updates the scope of earlier reporting on the expanding privacy case against the telehealth company, which had already drawn attention from consumers using app-based healthcare and subscription prescription services.

Why This Case Stands Out

Telehealth companies sit at the intersection of two areas regulators have been watching closely: health privacy and subscription design. Each issue alone can trigger scrutiny. Together, they can create a particularly significant enforcement risk.
On the privacy side, the case reflects the FTC’s broader position that companies cannot market themselves as privacy-protective while quietly passing along sensitive information to ad-tech platforms. Even when the allegations involve digital tools that many companies use for analytics or marketing, the legal question often turns on what data was shared, what promises were made, and whether consumers were given meaningful notice and choice.
On the subscription side, regulators have increasingly focused on what are often described as dark patterns—interface or process choices that may steer users into purchases, recurring billing, or friction-heavy cancellation flows. In this case, the amended complaint seeks to tie those concerns to the alleged failure to clearly disclose near-immediate prescription charges and to the alleged difficulty of stopping recurring payments.
That combination may help explain why more states joined the case. State attorneys general and local enforcement partners have shown growing interest in digital health, auto-renewals, and consumer-interface practices, particularly where vulnerable or intimate information is involved.

The Legal Framework Behind The Claims

The complaint relies in part on Section 5 of the FTC Act, which bars unfair or deceptive acts or practices, and on ROSCA, the federal statute aimed at online negative-option features and recurring charges. The amended complaint also adds state-law claims under consumer protection statutes in Arizona, Florida, Nebraska, Ohio, and Wisconsin, according to the FTC’s November 10 announcement.
In plain English, the privacy portion of the case appears to ask whether a company said one thing about protecting sensitive medical information while doing something materially different in practice. The billing portion appears to ask whether consumers were clearly told when charges would happen and whether stopping those charges was simple enough to satisfy the law.
That structure is familiar in modern FTC litigation. The agency often pairs broad deception theories with more specific subscription or billing statutes where recurring payments are involved. For consumers, that may sound technical, but the basic idea is relatively straightforward: what companies promise, what they disclose, and what they actually do can all become central evidence in court.

What It May Mean For Consumers

For the millions of people who use telehealth platforms, this case may raise uncomfortable but important questions about what happens behind the screen after they fill out an intake form about intimate medical issues.
Many users reasonably assume that online healthcare platforms treat disclosures about anxiety, depression, erectile dysfunction, hair loss, weight management, or other personal conditions with the same confidentiality expectations they would associate with a doctor’s office. This lawsuit does not resolve whether Hims & Hers violated the law; the FTC itself notes that a complaint reflects allegations to be decided by the court. But the case does show how aggressively regulators are examining the gap between privacy messaging and data-sharing practices.
On the subscription side, the allegations may also resonate with consumers who signed up for app-based health services expecting a consultation-first process, only to later question when charges were triggered or how difficult cancellation became. In situations like that, records often matter: account screens, cancellation attempts, emails, screenshots of checkout language, and bank or card statements can all become relevant when disputes involve recurring billing or online disclosures.

What Businesses And Affected Users May Be Watching Next

The FTC and state plaintiffs are seeking a permanent injunction, monetary relief, civil penalties, and other remedies in the amended case, according to the First Amended Complaint for permanent and monetary relief. If the government prevails on any meaningful portion of its claims, the outcome could influence how telehealth and subscription-based health platforms structure ad tracking, consent flows, intake forms, payment disclosures, and cancellation pathways.
Affected users may also be watching for a more practical reason: if a court record eventually sheds light on what information was shared, when it was shared, and how subscriptions were presented, that evidence could shape private disputes, consumer complaints, arbitration demands, or follow-on litigation. Some people in similar situations also look at whether the facts line up with broader patterns in the FTC’s consumer-privacy enforcement docket, especially when a platform handles information tied to medical treatment.
For businesses, the case may serve as another reminder that healthcare-adjacent technology is no longer treated like ordinary e-commerce. Companies that collect intimate health details while relying on marketing pixels, retargeting tools, and auto-renewal systems may face a far more exacting review than they would in a lower-sensitivity setting.
For consumers who believe private health information was exposed or who experienced confusing recurring charges, an attorney might help evaluate possible claims, arbitration issues, class action developments, or state-law remedies based on documented facts and account records. That kind of review can be especially valuable where privacy representations, payment timing, and cancellation barriers all appear in the same dispute.
If you're facing legal challenges, ReferU.AI analyzes billions of court records to match you with attorneys who've successfully represented cases just like yours.